Confo Therapeutics
Business Services · Belgium · 51-200 Employees
View Company Info for Free
Overview
Headquarters
Technologiepark-zwijnaarde 30, Gent, Fla...Phone Number
+32 93967400Website
www.confotherapeutics.comRevenue
$13.5 MillionIndustry
About Confo Therapeutics
Confo Therapeutics is a clinical-stage company focused on developing novel GPCR-directed medicines for metabolic and endocrine diseases. Utilizing proprietary technology, the company creates both small molecules and antibody-based therapies to address significant health challenges, including neuropathic pain and post-bariatric hypoglycemia. Their innovative approach targets GPCRs to discover new therapeutic options, and they actively collaborate with pharmaceutical partners to advance their pipeline. Confo Therapeutics aims to improve patient outcomes through cutting-edge research and development in the field of GPCR-modulating therapeutics.Explore more
SIC Code 87,873NAICS Code 54,541Show moreConfo Therapeutics Org Chart
Confo Therapeutics Tech Stack
A closer look at the technologies used by Confo Therapeutics
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Confo Therapeutics
Sign Up For FreeTo access detailed company insights
Confo Therapeutics is a clinical-stage company focused on developing novel GPCR-directed medicines for metabolic and endocrine diseases. Utilizing proprietary technology, the company creates both small molecules and antibody-based therapies to address significant health challenges, including neuropathic pain and post-bariatric hypoglycemia. Their i... Read More